Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia - PubMed (original) (raw)
Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia
K Nason-Burchenal et al. Proc Natl Acad Sci U S A. 1993.
Abstract
Insertional mutagenesis of c-myb by Moloney murine leukemia virus occurs in 100% of promonocytic leukemias (MMLS) induced by the virus. These leukemias, which resemble acute monocytic leukemia-M5 in humans are induced only in mice undergoing a peritoneal chronic inflammatory response. We have found that two leukemia-specific gag-myb mRNAs in MML provide molecular markers for detection of preleukemic cells in hematopoietic tissue in vivo. The two aberrant RNAs result from splicing of gag to either exon 3 or 4 of c-myb, depending on the site of proviral integration. After reverse transcription-PCR with nested primers and hybridization with specific gag-myb junction probes, one cell, having aberrant c-myb message, could be detected in a minimum of 10(5) liver cells or 10(6) spleen or bone-marrow cells. This approach was used to examine hematopoietic tissues of mice after pristane injection to induce inflammation and virus inoculation. Cells with gag-myb mRNAs could be detected as early as 2 weeks after virus inoculation. In mice receiving both pristane and virus, there was evidence of preleukemic cells in 83% of the mice by 3 weeks after virus infection. Furthermore, 100% of the mice were positive for preleukemic cells by 8 weeks, even though only 50% of mice have been shown to succumb to MML (peak time for disease latency is 12-16 weeks). Cells with these aberrant c-myb messages were initially detected in the bone marrow, but during intermediate stages of disease development these cells disseminated to the spleen, liver, and granuloma. At preleukemic times, from 3 to 8 weeks after virus infection, a lower percentage of mice were positive in the group that did not receive pristane compared with mice in the group receiving pristane. However, at 18 weeks, 100% of the mice in the group receiving virus only had evidence of cells expressing gag-myb RNA in their spleens and/or bone marrow; it is of interest that mice inoculated with virus alone never develop MML. This approach for detecting preleukemic cells will now allow the study of mechanisms by which these preleukemic cells progress to a more transformed state and, perhaps, to a more differentiated state.
Similar articles
- Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V, Hilbert D, Wolff L. Nazarov V, et al. Virology. 1994 Dec;205(2):479-85. doi: 10.1006/viro.1994.1668. Virology. 1994. PMID: 7975249 - New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.
Mukhopadhyaya R, Wolff L. Mukhopadhyaya R, et al. J Virol. 1992 Oct;66(10):6035-44. doi: 10.1128/JVI.66.10.6035-6044.1992. J Virol. 1992. PMID: 1527851 Free PMC article. - Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions.
Mukhopadhyaya R, Richardson J, Nazarov V, Corbin A, Koller R, Sitbon M, Wolff L. Mukhopadhyaya R, et al. J Virol. 1994 Aug;68(8):5100-7. doi: 10.1128/JVI.68.8.5100-5107.1994. J Virol. 1994. PMID: 7518530 Free PMC article. - Mechanism of activation of the myb oncogene in myeloid leukemias.
Rosson D, Reddy EP. Rosson D, et al. Ann N Y Acad Sci. 1987;511:219-31. doi: 10.1111/j.1749-6632.1987.tb36250.x. Ann N Y Acad Sci. 1987. PMID: 3326465 Review. No abstract available. - Retroviral insertional mutagenesis in murine promonocytic leukemias: c-myb and Mml1.
Wolff L, Koller R, Bies J, Nazarov V, Hoffman B, Amanullah A, Krall M, Mock B. Wolff L, et al. Curr Top Microbiol Immunol. 1996;211:191-9. doi: 10.1007/978-3-642-85232-9_19. Curr Top Microbiol Immunol. 1996. PMID: 8585950 Review.
Cited by
- Three murine leukemia virus integration regions within 100 kilobases upstream of c-myb are proximal to the 5' regulatory region of the gene through DNA looping.
Zhang J, Markus J, Bies J, Paul T, Wolff L. Zhang J, et al. J Virol. 2012 Oct;86(19):10524-32. doi: 10.1128/JVI.01077-12. Epub 2012 Jul 18. J Virol. 2012. PMID: 22811527 Free PMC article. - Impairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus.
Sørensen AB, Lund AH, Kunder S, Quintanilla-Martinez L, Schmidt J, Wang B, Wabl M, Pedersen FS. Sørensen AB, et al. Retrovirology. 2007 Jul 6;4:46. doi: 10.1186/1742-4690-4-46. Retrovirology. 2007. PMID: 17617899 Free PMC article. - Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.
Le Rouzic E, Perbal B. Le Rouzic E, et al. J Virol. 1996 Nov;70(11):7414-23. doi: 10.1128/JVI.70.11.7414-7423.1996. J Virol. 1996. PMID: 8892859 Free PMC article. - Myb proteins: angels and demons in normal and transformed cells.
Zhou Y, Ness SA. Zhou Y, et al. Front Biosci (Landmark Ed). 2011 Jan 1;16(3):1109-31. doi: 10.2741/3738. Front Biosci (Landmark Ed). 2011. PMID: 21196221 Free PMC article. Review. - Differential selection of cells with proviral c-myc and c-erbB integrations after avian leukosis virus infection.
Gong M, Semus HL, Bird KJ, Stramer BJ, Ruddell A. Gong M, et al. J Virol. 1998 Jul;72(7):5517-25. doi: 10.1128/JVI.72.7.5517-5525.1998. J Virol. 1998. PMID: 9621008 Free PMC article.
References
- Virology. 1970 Dec;42(4):1136-9 - PubMed
- Cancer Res. 1992 Oct 1;52(19):5317-22 - PubMed
- J Immunol. 1978 Aug;121(2):641-7 - PubMed
- Nature. 1981 Oct 15-21;293(5833):543-8 - PubMed
- Recent Results Cancer Res. 1984;93:51-68 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases